TMEM106B expression can be reduced in the brains of AD patients,26 and some studies have shown that loss of TMEM106B can induce severe lysosomal abnormalities in neurodegenerative models, especially in the context of PGRN loss.21, 36, 65. The gene discussed is TMEM106B; the disease is Alzheimer disease.